Report-at-a-Glance
New England CEPAC

PDF cover

Hemophilia A: Report-at-a-Glance

A summary of ICER’s report reviewing the clinical effectiveness and value of emicizumab for patients with hemophilia A and inhibitors to factor VIII.

View

View All Materials on this Topic or Go Back to View More Materials